FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894571372> ?p ?o ?g. }

• W2894571372 endingPage "141" @default.
• W2894571372 startingPage "131" @default.
• W2894571372 abstract "Abstract Introduction Curative radiotherapy is guideline treatment for inoperable patients of good performance status with Stage I & II Non‐Small Cell Lung Cancer ( NSCLC ). The aim of this study was to evaluate radiotherapy patterns of care in these patients, the reasons for palliative treatment and the proportion of patients suitable for curative stereotactic ablative body radiotherapy ( SABR ). Methods Electronic oncology databases at three institutions were queried to retrieve data on patients with inoperable Stage I & II NSCLC seen in radiation oncology clinics between 1/1/2008 and 31/12/2014. Suitability for SABR was defined as peripheral tumours less than 5 cm in size. Factors associated with curative treatment were determined using univariate and multivariate analyses. Results Three‐hundred‐and‐twelve patients were identified of whom 178 (57%) received curative radiotherapy, 58 (19%) palliative radiotherapy and 76 (24%) no radiotherapy. The main reason for receiving palliative rather than curative treatment was COPD or poor pulmonary function (26%). Method of diagnosis ( P = 0.031), Simplified Comorbidity Score ( P = 0.003), ECOG performance status ( P = 0.016), FEV 1% ( P = 0.040), treating institution ( P < 0.0001) and time period ( P = 0.016) were associated with curative radiotherapy on multivariate analysis. In patients with T1‐2N0M0 NSCLC , 19 (31%) who did not receive treatment and 7 (21%) who underwent palliative radiotherapy were technically and clinically suitable for SABR . Conclusion Only 57% of patients with Stage I‐ II NSCLC were treated with curative radiotherapy. Patient factors were the predominant reason for palliative treatment, however, treating institution also played a role. A considerable proportion of patients who underwent palliative or no radiotherapy were suitable for SABR treatment." @default.
• W2894571372 created "2018-10-12" @default.
• W2894571372 creator A5018783860 @default.
• W2894571372 creator A5037661832 @default.
• W2894571372 creator A5052648825 @default.
• W2894571372 creator A5056178574 @default.
• W2894571372 creator A5084635226 @default.
• W2894571372 creator A5091869927 @default.
• W2894571372 date "2018-10-03" @default.
• W2894571372 modified "2023-10-14" @default.
• W2894571372 title "Radiotherapy patterns of care for stage I and <scp>II</scp> non‐small cell lung cancer in Sydney, Australia" @default.
• W2894571372 cites W1757407923 @default.
• W2894571372 cites W1843371711 @default.
• W2894571372 cites W1976182450 @default.
• W2894571372 cites W1984219436 @default.
• W2894571372 cites W1997836338 @default.
• W2894571372 cites W2013138562 @default.
• W2894571372 cites W2019143259 @default.
• W2894571372 cites W2019737736 @default.
• W2894571372 cites W2026650308 @default.
• W2894571372 cites W2029060680 @default.
• W2894571372 cites W2041992600 @default.
• W2894571372 cites W2042183844 @default.
• W2894571372 cites W2050158980 @default.
• W2894571372 cites W2058429319 @default.
• W2894571372 cites W2069534896 @default.
• W2894571372 cites W2069562788 @default.
• W2894571372 cites W2072729670 @default.
• W2894571372 cites W2077982938 @default.
• W2894571372 cites W2092014242 @default.
• W2894571372 cites W2095067115 @default.
• W2894571372 cites W2096138258 @default.
• W2894571372 cites W2099056299 @default.
• W2894571372 cites W2100101054 @default.
• W2894571372 cites W2101751898 @default.
• W2894571372 cites W2114152921 @default.
• W2894571372 cites W2114925293 @default.
• W2894571372 cites W2115646671 @default.
• W2894571372 cites W2120593592 @default.
• W2894571372 cites W2131441386 @default.
• W2894571372 cites W2131914710 @default.
• W2894571372 cites W2137651370 @default.
• W2894571372 cites W2140375432 @default.
• W2894571372 cites W2148689546 @default.
• W2894571372 cites W2153943945 @default.
• W2894571372 cites W2157520038 @default.
• W2894571372 cites W2158550046 @default.
• W2894571372 cites W2159746573 @default.
• W2894571372 cites W2170603432 @default.
• W2894571372 cites W2766311106 @default.
• W2894571372 cites W2767454104 @default.
• W2894571372 doi "https://doi.org/10.1111/1754-9485.12819" @default.
• W2894571372 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30281917" @default.
• W2894571372 hasPublicationYear "2018" @default.
• W2894571372 type Work @default.
• W2894571372 sameAs 2894571372 @default.
• W2894571372 citedByCount "5" @default.
• W2894571372 countsByYear W28945713722020 @default.
• W2894571372 countsByYear W28945713722021 @default.
• W2894571372 countsByYear W28945713722022 @default.
• W2894571372 crossrefType "journal-article" @default.
• W2894571372 hasAuthorship W2894571372A5018783860 @default.
• W2894571372 hasAuthorship W2894571372A5037661832 @default.
• W2894571372 hasAuthorship W2894571372A5052648825 @default.
• W2894571372 hasAuthorship W2894571372A5056178574 @default.
• W2894571372 hasAuthorship W2894571372A5084635226 @default.
• W2894571372 hasAuthorship W2894571372A5091869927 @default.
• W2894571372 hasBestOaLocation W28945713721 @default.
• W2894571372 hasConcept C106159729 @default.
• W2894571372 hasConcept C121608353 @default.
• W2894571372 hasConcept C126322002 @default.
• W2894571372 hasConcept C143998085 @default.
• W2894571372 hasConcept C144301174 @default.
• W2894571372 hasConcept C146357865 @default.
• W2894571372 hasConcept C151730666 @default.
• W2894571372 hasConcept C159110408 @default.
• W2894571372 hasConcept C162324750 @default.
• W2894571372 hasConcept C187625094 @default.
• W2894571372 hasConcept C2776256026 @default.
• W2894571372 hasConcept C2776907518 @default.
• W2894571372 hasConcept C2994186709 @default.
• W2894571372 hasConcept C38180746 @default.
• W2894571372 hasConcept C509974204 @default.
• W2894571372 hasConcept C71924100 @default.
• W2894571372 hasConcept C85393063 @default.
• W2894571372 hasConcept C86803240 @default.
• W2894571372 hasConcept C91602232 @default.
• W2894571372 hasConceptScore W2894571372C106159729 @default.
• W2894571372 hasConceptScore W2894571372C121608353 @default.
• W2894571372 hasConceptScore W2894571372C126322002 @default.
• W2894571372 hasConceptScore W2894571372C143998085 @default.
• W2894571372 hasConceptScore W2894571372C144301174 @default.
• W2894571372 hasConceptScore W2894571372C146357865 @default.
• W2894571372 hasConceptScore W2894571372C151730666 @default.
• W2894571372 hasConceptScore W2894571372C159110408 @default.
• W2894571372 hasConceptScore W2894571372C162324750 @default.
• W2894571372 hasConceptScore W2894571372C187625094 @default.
• W2894571372 hasConceptScore W2894571372C2776256026 @default.

• next